|
MAK16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.374500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.000440E-02 |
| Normal-vs-Stage2 |
6.897700E-02 |
| Normal-vs-Stage3 |
7.768400E-04 |
| Normal-vs-Stage4 |
2.819200E-03 |
| Stage1-vs-Stage2 |
8.624200E-01 |
| Stage1-vs-Stage3 |
5.400200E-02 |
| Stage1-vs-Stage4 |
1.888770E-01 |
| Stage2-vs-Stage3 |
3.314000E-01 |
| Stage2-vs-Stage4 |
4.879400E-01 |
| Stage3-vs-Stage4 |
7.222000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.882200E-03 |
| Normal-vs-AfricanAmerican |
1.412350E-02 |
| Normal-vs-Asian |
2.995000E-01 |
| Caucasian-vs-AfricanAmerican |
6.045200E-01 |
| Caucasian-vs-Asian |
9.736000E-01 |
| AfricanAmerican-vs-Asian |
8.804000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.321410E-03 |
| Normal-vs-Female |
2.823700E-02 |
| Male-vs-Female |
7.929700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.154200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.122350E-02 |
| Normal-vs-Age(61-80Yrs) |
1.162120E-03 |
| Normal-vs-Age(81-100Yrs) |
5.258400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.055600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.045600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.466000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.388640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.642400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.650400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.252600E-01 |
| Normal-vs-Grade 2 |
9.105800E-02 |
| Normal-vs-Grade 3 |
1.966450E-04 |
| Normal-vs-Grade 4 |
9.353000E-04 |
| Grade 1-vs-Grade 2 |
6.445600E-01 |
| Grade 1-vs-Grade 3 |
5.854400E-02 |
| Grade 1-vs-Grade 4 |
8.012500E-02 |
| Grade 2-vs-Grade 3 |
3.978800E-04 |
| Grade 2-vs-Grade 4 |
1.412480E-02 |
| Grade 3-vs-Grade 4 |
9.938400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.313700E-02 |
| Normal-vs-ccB subtype |
2.415500E-03 |
| ccA subtype-vs-ccB subtype |
3.147900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.262400E-03 |
| Normal-vs-N1 |
3.562000E-01 |
| N0-vs-N1 |
5.302200E-01 |
|
|
